View Item 

Show simple item record

The Drug Shortage Era: A Scoping Review of the Literature 2001–2019
dc.contributor.authorTucker, Emily L.
dc.contributor.authorCao, Yizhou
dc.contributor.authorFox, Erin R.
dc.contributor.authorSweet, Burgunda V.
dc.date.accessioned2020-12-02T14:42:29Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-12-02T14:42:29Z
dc.date.issued2020-12
dc.identifier.citationTucker, Emily L.; Cao, Yizhou; Fox, Erin R.; Sweet, Burgunda V. (2020). "The Drug Shortage Era: A Scoping Review of the Literature 2001–2019." Clinical Pharmacology & Therapeutics 108(6): 1150-1155.
dc.identifier.issn0009-9236
dc.identifier.issn1532-6535
dc.identifier.urihttps://hdl.handle.net/2027.42/163655
dc.publisherWiley Periodicals, Inc.
dc.titleThe Drug Shortage Era: A Scoping Review of the Literature 2001–2019
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPharmacy and Pharmacology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163655/3/cpt1934-sup-0001-Supinfo.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163655/2/cpt1934.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163655/1/cpt1934_am.pdfen_US
dc.identifier.doi10.1002/cpt.1934
dc.identifier.sourceClinical Pharmacology & Therapeutics
dc.identifier.citedreferenceGottlieb, S. Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long‐term solutions to prevent shortages < https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm613346.htm > ( 2018 ).
dc.identifier.citedreferenceDill, S. & Ahn, J. Drug shortages in developed countries ‐ reasons, therapeutic consequences, and handling. Eur. J. Clin. Pharmacol. 70, 1405 – 1412 ( 2014 ).
dc.identifier.citedreferenceCouncil on Science and Public Health. Drug Shortages: Update (2‐A‐18) < https://www.ama‐assn.org/councils/council‐science‐public‐health/prescription‐drugs‐csaph‐reports > ( 2018 ).
dc.identifier.citedreferenceMazer‐Amirshahi, M. & Fox, E.R. Saline shortages — many causes, no simple solution. N. Engl. J. Med. 378, 1472 – 1474 ( 2018 ).
dc.identifier.citedreferenceISPE report on the ISPE drug shortages survey < https://ispe.org/sites/default/files/initiatives/drug‐shortages/2013‐ISPE‐drug‐shortages‐survey‐report.pdf > ( 2013 ).
dc.identifier.citedreferenceObama, B. Executive order 13588 – reducing prescription drug shortages < https://obamawhitehouse.archives.gov/the‐press‐office/2011/10/31/executive‐order‐13588‐reducing‐prescription‐drug‐shortages > ( 2011 ).
dc.identifier.citedreferenceUS Food and Drug Administration (FDA). FDA report on drug shortages for calendar year 2017 < https://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM610662.pdf > ( 2017 ).
dc.identifier.citedreferenceChan, L.‐N. Iatrogenic malnutrition: a serious public health issue caused by drug shortages. J. Parenter. Enter. Nutr. 37, 702 – 704 ( 2013 ).
dc.identifier.citedreferenceMcLaughlin, M.M., Lin, J., Nguyen, R., Patel, P. & Fox, E.R. Unavailability of outpatient medications: examples and opportunities for management. J. Pharm. Technol. 33, 83 – 86 ( 2017 ).
dc.identifier.citedreferenceCorrigan, M. & Kirby, D.F. Impact of a national shortage of sterile ethanol on a home parenteral nutrition practice: a case series. J. Parenter. Enter. Nutr. 36, 476 – 480 ( 2012 ).
dc.identifier.citedreferencePatel, S., Liedtke, M., Ngo, D. & Medeiros, B.C. A single‐center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia. Leuk. Lymphoma 54, 2231 – 2235 ( 2013 ).
dc.identifier.citedreferenceMetzger, M.L., Billett, A. & Link, M.P. The impact of drug shortages on children with cancer–the example of mechlorethamine. N. Engl. J. Med. 367, 2461 – 2463 ( 2012 ).
dc.identifier.citedreferenceBhat, S., Roberts, R. & Devlin, J.W. Posted versus actual drug shortages. Am. J. Health Pharm. 69, 1363 – 1364 ( 2012 ).
dc.identifier.citedreferenceMcLaughlin, M.M., Pentoney, Z., Skoglund, E. & Scheetz, M.H. Projections for antiinfective drug shortages and time to actual resolution. Am. J. Health Pharm. 71, 2074 – 2078 ( 2014 ).
dc.identifier.citedreferenceHolmes, O.W. & Hughes, P.J. Drug shortage management in Alabama hospital pharmacies. Innov. Pharm. 4, ( 2013 ).
dc.identifier.citedreferenceVanek, V.W. et al. A call to action for optimizing the electronic health record in the parenteral nutrition workflow. Am. J. Health Pharm. 75, 1400 – 1420 ( 2018 ).
dc.identifier.citedreferenceCouncil on science and public health Drug shortages: 2019 update (2‐A‐19) < https://www.ama‐assn.org/system/files/2019‐05/a19‐csaph2.pdf > ( 2019 ).
dc.identifier.citedreferenceFrosch, Z.A.K. et al. Cancer drug shortages: awareness and perspectives from a representative sample of the US population. Cancer 124, 2205 – 2211 ( 2018 ).
dc.identifier.citedreferenceGovernment Accountability Office (GAO). GAO‐16‐595: drug shortages: certain factors are strongly associated with this persistent public health challenge < https://www.gao.gov/products/GAO‐16‐595 > ( 2016 ).
dc.identifier.citedreferenceIdentifying the root causes of drug shortages and finding enduring solutions < https://healthpolicy.duke.edu/sites/default/files/atoms/files/duke‐fda_drug_shortages_presentation_slides__0.pdf > ( 2018 ).
dc.identifier.citedreferenceHassig, T.B., McKinzie, B.P., Fortier, C.R. & Taber, D. Clinical management strategies and implications for parenteral nutrition drug shortages in adult patients. Pharmacotherapy 34, 72 – 84 ( 2014 ).
dc.identifier.citedreferenceHosseini, R. et al. Factors associated with the incidence of oncology drugs shortages in the United States (2001–2017). Value Health 21, S372 ( 2018 ).
dc.identifier.citedreferenceAmerican Hospital Association. AHA survey on drug shortages < https://www.aha.org/system/files/content/11/drugshortagesurvey.pdf > ( 2011 ).
dc.identifier.citedreferenceHantel, A., Siegler, M., Hlubocky, F., Colgan, K. & Daugherty, C.K. Prevalence and severity of rationing during drug shortages. JAMA Intern. Med. 179, 710 – 711 ( 2019 ).
dc.identifier.citedreferenceKehl, K.L. et al. Oncologists’ experiences with drug shortages. J. Oncol. Pract. 11, e154 – e162 ( 2015 ).
dc.identifier.citedreferenceVail, E. et al. Association between US norepinephrine shortage and mortality among patients with septic shock. J. Am. Med. Assoc. 317, 1433 – 1442 ( 2017 ).
dc.identifier.citedreferenceVizient Drug shortages and labor costs < https://www.vizientinc.com/‐/media/documents/sitecorepublishingdocuments/public/vzdrugshortageslaborcost_fullreport.pdf > ( 2019 ).
dc.identifier.citedreferenceUS Food and Drug Administration (FDA). FDA drug shortages task force drug shortages: root causes and potential solutions < https://www.fda.gov/media/132059/download > ( 2019 ).
dc.identifier.citedreferenceArksey, H. & O’Malley, L. Scoping studies: towards a methodological framework. Int. J. Soc. Res. Methodol. Theory Pract. 8, 19 – 32 ( 2005 ).
dc.identifier.citedreferenceTricco, A.C. et al. PRISMA extension for scoping reviews (PRISMA‐ScR): checklist and explanation. Ann. Intern. Med. 169, 467 – 473 ( 2018 ).
dc.identifier.citedreferenceRidley, D.B., Bei, X. & Liebman, E.B. No shot: US vaccine prices and shortages. Health Aff. 35, 235 – 241 ( 2016 ).
dc.identifier.citedreferenceAmerican Society of Health‐System Pharmacists (ASHP). ASHP current drug shortages < https://www.ashp.org/drug‐shortages/current‐shortages > ( 2019 ).
dc.identifier.citedreferenceUS Food and Drug Administration (FDA). FDA drug shortages < https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm > ( 2019 ).
dc.identifier.citedreferenceBanerjee, R., Thurm, C.W., Fox, E.R. & Hersh, A.L. Antibiotic shortages in pediatrics. Pediatrics 142, e20180858 ( 2018 ).
dc.identifier.citedreferenceMazer‐Amirshahi, M. et al. U.S. drug shortages for medications used in adult critical care (2001–2016). J. Crit. Care 41, 283 – 288 ( 2017 ).
dc.identifier.citedreferenceUS Food and Drug Administration Safety and Innovation Act (FDASIA). Public Law 112–144 < https://www.congress.gov/112/plaws/publ144/PLAW‐112publ144.pdf > ( 2012 ).
dc.identifier.citedreferenceGatesman, M.L. & Smith, T.J. The shortage of essential chemotherapy drugs in the United States. N. Engl. J. Med. 365, 1653 – 1655 ( 2011 ).
dc.identifier.citedreferenceInstitute for Safe Medication Practices (ISMP). ISMP Drug shortages: National Survey Reveals High Level of Frustration, Low Level of Safety. ISMP Medicat. Saf. Alert! < http://www.ismp.org/resources/special‐issue‐drug‐shortages‐national‐survey‐reveals‐high‐level‐frustration‐low‐level > ( 2010 ).
dc.identifier.citedreferenceDe Oliveira, G.S., Theilken, L.S. & McCarthy, R.J. Shortage of perioperative drugs: implications for anesthesia practice and patient safety. Anesth. Analg. 113, 1429 – 1435 ( 2011 ).
dc.identifier.citedreferenceGundlapalli, A.V., Beekmann, S.E., Graham, D.R. & Polgreen, P.M. & Members of the Emerging Infectious Network. Antimicrobial agent shortages: the new norm for infectious diseases physicians. Open Forum Infect. Dis. 5, 1 – 5 ( 2018 ).
dc.identifier.citedreferenceIMS Institute for Healthcare Informatics. Drug shortages: a closer look at products, suppliers and volume volatility <https://www.puncturemovie.com/wp‐content/themes/Romix/pdfs/ihii‐drug‐shortage‐report.pdf> ( 2011 ).
dc.identifier.citedreferenceAlpert, A. & Jacobson, M. Impact of oncology drug shortages on chemotherapy treatment. Clin. Pharmacol. Ther. 106, 415 – 421 ( 2019 ).
dc.identifier.citedreferenceKaakeh, R. et al. Impact of drug shortages on U.S. health systems. Am. J. Health Pharm. 68, 1811 – 1819 ( 2011 ).
dc.identifier.citedreferenceCherici, C. et al. Navigating drug shortages in American healthcare: a premier healthcare alliance analysis < https://www.heartland.org/publications‐resources/publications/navigating‐drug‐shortages‐in‐american‐healthcare‐a‐premier‐healthcare‐alliance‐analysis > ( 2011 ).
dc.identifier.citedreferenceReed, B.N. et al. The impact of drug shortages on patients with cardiovascular disease: causes, consequences, and a call to action. Am. Heart J. 175, 130 – 141 ( 2016 ).
dc.identifier.citedreferenceFox, E.R. & McLaughlin, M.M. ASHP guidelines on managing drug product shortages. Am. J. Health Pharm. 75, 1742 – 1750 ( 2018 ).
dc.identifier.citedreferenceWoodcock, J. & Wosinska, M. Economic and technological drivers of generic sterile injectable drug shortages. Clin. Pharmacol. Ther. 93, 170 – 176 ( 2013 ).
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cpt1934_am.pdf
Size:
312.4KB
Format:
PDF
View/Open
Name:
cpt1934.pdf
Size:
164.2KB
Format:
PDF
View/Open
Name:
cpt1934-sup-0001-Supinfo.pdf
Size:
791.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.